MMC vs REPL · P/E 22, rev $24.46B vs $825.7M cap
Marsh & McLennan Companies Inc (MMC) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
REPL does not have a complete income-statement cache yet.
MMC currently screens at market cap $89.82B and trailing P/E 21.9. REPL currently screens at market cap $825.7M.
Not investment advice. Open the MMC and REPL stock pages for the full models.
Not investment advice.